EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL).

AT-19 is under clinical development by Shanghai YaKe Biotechnology and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).

Charlotte Cave, a 3-year old girl is battling B-Cell Acute Lymphoblastic Leukemia, along with medical trauma and anxiety.

Chronic lymphocytic leukemia (CLL) is categorized as a mature B-cell neoplasm, under the subcategory of pre-neoplastic and neoplastic small lymphocytic proliferations, according to the 5th edition of ...

One of the study’s bright spots is that Hispanic children, who have higher rates of B-cell acute lymphoblastic leukemia and worse outcomes, had proportionally greater benefit from blinatumomab.

T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), a type of white blood cell. T lymphocytes (T cells) and B lymphocytes ... are found. Leukemia starts in the ...

5, 2024 — Stem cell transplantation is used to treat ... lifetime could have implications for the treatment of acute myeloid leukemia and ...

Professor Michel Sadelain and Professor Sumio Iijima, among other eminent figures, were selected to win the 47th session of ...

HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically.

Blues musicians from around the country will perform at a fundraiser for former Colorado Springs blues and rock musician ...

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

The corticotropic-releasing hormone enhances the bone-marrow homing and engraftment of human haematopoietic stem and progenitor cells via the mechanical remodelling of the cell’s cytoskeleton ...